Package 67877-882-71

Brand: rivaroxaban

Generic: rivaroxaban
NDC Package

Package Facts

Identity

Package NDC 67877-882-71
Digits Only 6787788271
Product NDC 67877-882
Product ID 67877-882_d111f8d6-a073-4a43-bf16-bc1bacba9898
Description

1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2025-07-07
Brand rivaroxaban
Generic rivaroxaban
Sample Package No

Linked Drug Pages (1)

Rivaroxaban ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d111f8d6-a073-4a43-bf16-bc1bacba9898", "openfda": {"nui": ["N0000175635", "N0000175637"], "upc": ["0367877882710"], "unii": ["9NDF7JZ4M3"], "rxcui": ["2588062"], "spl_set_id": ["c0efa9f9-ca7a-471a-8030-99056fa5da09"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (67877-882-71)  / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE", "package_ndc": "67877-882-71", "marketing_start_date": "20250707"}], "brand_name": "Rivaroxaban", "product_id": "67877-882_d111f8d6-a073-4a43-bf16-bc1bacba9898", "dosage_form": "GRANULE, FOR SUSPENSION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "67877-882", "generic_name": "Rivaroxaban", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivaroxaban", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "155 mg/1"}], "application_number": "ANDA218502", "marketing_category": "ANDA", "marketing_start_date": "20250707", "listing_expiration_date": "20261231"}